Literature DB >> 18175089

Inhalation anaesthesia: from diethyl ether to xenon.

J G Bovill1.   

Abstract

Modern anaesthesia is said to have began with the successful demonstration of ether anaesthesia by William Morton in October 1846, even though anaesthesia with nitrous oxide had been used in dentistry 2 years before. Anaesthesia with ether, nitrous oxide and chloroform (introduced in 1847) rapidly became commonplace for surgery. Of these, only nitrous oxide remains in use today. All modern volatile anaesthetics, with the exception of halothane (a fluorinated alkane), are halogenated methyl ethyl ethers. Methyl ethyl ethers are more potent, stable and better anaesthetics than diethyl ethers. They all cause myocardial depression, most markedly halothane, while isoflurane and sevoflurane cause minimal cardiovascular depression. The halogenated ethers also depress the normal respiratory response to carbon dioxide and to hypoxia. Other adverse effects include hepatic and renal damage. Hepatitis occurs most frequently with halothane, although rare cases have been reported with the other agents. Liver damage is not caused by the anaesthetics themselves, but by reactive metabolites. Type I hepatitis occurs fairly commonly and takes the form of a minor disturbance of liver enzymes, which usually resolves without treatment. Type II, thought to be immune-mediated, is rare, unpredictable and results in a severe fulminant hepatitis with a high mortality. Renal damage is rare, and was most often associated with methoxyflurane because of excessive plasma fluoride concentrations resulting from its metabolism. Methoxyflurane was withdrawn from the market because of the high incidence of nephrotoxicity. Among the contemporary anaesthetics, the highest fluoride concentrations have been reported with sevoflurane, but there are no reports of renal dysfunction associated with its use. Recently there has been a renewed interest in xenon, one of the noble gases. Xenon has many of the properties of an ideal anaesthetic. The major factor limiting its more widespread is the high cost, about 2,000 times the cost of nitrous oxide.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18175089     DOI: 10.1007/978-3-540-74806-9_6

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  8 in total

Review 1.  The Role of GABA Receptor Agonists in Anesthesia and Sedation.

Authors:  Janette Brohan; Basavana G Goudra
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

2.  Ketamine-xylazine-acepromazine compared with isoflurane for anesthesia during liver transplantation in rodents.

Authors:  Songqing He; Carl Atkinson; Fei Qiao; Xiaoping Chen; Stephen Tomlinson
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-01       Impact factor: 1.232

3.  Genetic effects in Drosophila on the potency of diverse general anesthetics: a distinctive pattern of altered sensitivity.

Authors:  Joseph L Campbell; Qun Gu; Dongyu Guo; Howard A Nash
Journal:  J Neurogenet       Date:  2009       Impact factor: 1.250

4.  Comparison of speed of inhalational induction in children with and without congenital heart disease.

Authors:  Suruchi Hasija; Sandeep Chauhan; Pawan Jain; Arin Choudhury; Neelam Aggarwal; Ravinder Kumar Pandey
Journal:  Ann Card Anaesth       Date:  2016 Jul-Sep

Review 5.  Perioperative Evaluation of Patients with Pulmonary Conditions Undergoing Non-Cardiothoracic Surgery.

Authors:  Gilda Diaz-Fuentes; Hafiz Rizwan Talib Hashmi; Sindhaghatta Venkatram
Journal:  Health Serv Insights       Date:  2016-11-09

6.  An observational study on patient admission in the anaesthesia gas monitor and minimum alveolar concentration monitoring: A deficiency with huge impact.

Authors:  Habib Md Reazaul Karim; Anilkumar Narayan; Md Yunus; Sanjay Kumar; Avinash Prakash; Sarasa Kumar Sahoo
Journal:  Indian J Anaesth       Date:  2017-07

7.  XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia.

Authors:  Ecem Esencan; Simge Yuksel; Yusuf Berk Tosun; Alexander Robinot; Ihsan Solaroglu; John H Zhang
Journal:  Med Gas Res       Date:  2013-02-01

8.  Xenon: a solution for anesthesia in liver disease?

Authors:  Ali Dabbagh; Samira Rajaei
Journal:  Hepat Mon       Date:  2012-11-20       Impact factor: 0.660

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.